An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression
Research over the last two decades has established ketamine as a safe, effective, fast-acting, and sustained antidepressant that significantly reduces adverse symptoms associated with depression, even in patients who are treatment resistant. Much of this research has evolved within the framework of...
Saved in:
Main Authors: | Sherry-Anne Muscat, Glenn Hartelius, Courtenay Richards Crouch, Kevin W. Morin |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a499c78a4b10447d8cf867dd4fa082f1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunoregulation and antidepressant effect of ketamine
by: Zhang Nan, et al.
Published: (2021) -
Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy
by: Anya Ragnhildstveit, et al.
Published: (2021) -
Procedural moderate sedation with ketamine in pediatric critical care unit
by: Tarek R Hazwani, et al.
Published: (2017) -
Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
by: Mateusz Kowalczyk, et al.
Published: (2021) -
Deficits in N-Methyl-D-Aspartate Receptor Function and Synaptic Plasticity in Hippocampal CA1 in APP/PS1 Mouse Model of Alzheimer’s Disease
by: Le Xu, et al.
Published: (2021)